MiMedx Group, Inc. (OTCBB: MDXG) is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. “Innovations in Regenerative Biomaterials” is the framework behind the Company’s mission to give physicians products and tissues to help the body heal itself. Its biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, as well as tissue technologies, AmnioFix® and EpiFix®. For further information, visit the Company’s Web site at www.mimedx.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: